Ionis to host 2024 virtual Annual Meeting of Stockholders

Rhea-AI Summary

Ionis Pharmaceuticals announced it will hold its 2024 virtual Annual Meeting of Stockholders on June 6, 2024. The event will start at 5:00 p.m. ET, with stockholders of record as of April 8, 2024, invited to participate. A general corporate update, including a Q&A session, will follow at 5:30 p.m. ET, presented by CEO Brett P. Monia. Stockholders will receive proxy cards needed to log in, vote, and submit questions. Technical assistance will be available. The event will be webcast live, with an archived replay available later.

Positive

• Ionis is engaging stockholders through a virtual annual meeting, increasing accessibility.
• Stockholders can vote and ask questions live, promoting transparency.
• CEO Brett P. Monia will provide a corporate update, offering insights into the company's future direction.
• The event will be archived for those unable to attend live, ensuring wider reach.

Negative

• No replay of the stockholders' meeting session will be available, limiting access for those unable to attend live.
• Stockholders may face difficulties obtaining proxy cards and control numbers, potentially hindering participation.

CARLSBAD, Calif., May 15, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2024 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 6, 2024.

The agenda for the event is as follows:

• 5:00 p.m. – 5:15 p.m. ET (2:00 p.m. – 2:15 p.m. PT) – Virtual Annual Meeting of Stockholders 
  • All stockholders of record at the close of business on April 8, 2024, are invited to participate in the virtual Annual Meeting webcast, which will be broadcast live at http://www.virtualshareholdermeeting.com/IONS2024.
    
    
  • Stockholders of record will receive an official proxy card from their brokerage firm. Each proxy card contains a 16-digit control number required to log-in, vote and submit questions during the webcast.
    
    
  • Ionis does not provide proxy cards or have access to proxy card information, including 16-digit control numbers. For help obtaining a proxy card or to locate their control number or for instructions to access the webcast, stockholders of record should contact their brokerage firm before Thursday, May 23.
    
    
  • A help line will be available on the registration page of the live webcast for participants requiring technical assistance in accessing or participating during the live event. There will not be a replay of this session.
• 5:30 p.m. ET (2:30 p.m. PT) – Virtual corporate update
  • Brett P. Monia, Ph.D., Ionis' chief executive officer, will provide a general corporate update followed by a question-and-answer session.
    
    
  • All interested parties may access the webcast live at https://event.webcasts.com/starthere.jsp?ei=1659973&tp_key=9ca016319a. An archived replay of the webcast will be posted for a limited time following the meeting at that same address.
    
    
  • Questions for management may be submitted in advance of the webcast and will be addressed during the question-and-answer portion of the webcast. Please submit questions via email to IonisAnnualMeeting@ionisph.com by Tuesday, June 4. Questions not addressed during the webcast will be answered by email following the meeting.

About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – info@ionisph.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – CorporateCommunications@ionisph.com – 760-603-4679

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-host-2024-virtual-annual-meeting-of-stockholders-302145477.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

When is the Ionis 2024 Annual Meeting of Stockholders?

The Ionis 2024 Annual Meeting of Stockholders is on June 6, 2024, at 5:00 p.m. ET.

How can I participate in the Ionis 2024 Annual Meeting of Stockholders?

Stockholders of record as of April 8, 2024, can participate by accessing the live webcast at http://www.virtualshareholdermeeting.com/IONS2024 using their 16-digit control number.

What happens if I experience technical issues during the Ionis 2024 Annual Meeting?

A help line will be available on the registration page of the live webcast for technical assistance.

Will there be a replay available for the Ionis 2024 Annual Meeting?

No replay will be available for the stockholders' meeting session. However, the corporate update session will have an archived replay.

How can I submit questions for the Ionis 2024 Annual Meeting?

Questions can be submitted in advance via email to IonisAnnualMeeting@ionisph.com by June 4, 2024.